Search research articles
Contact Us
Filters
Showing results (141-150 of 430) with videos related to
Page
of 43
Sort By:
Clinical Lymphoma, Myeloma & Leukemia
|
July 29, 2014
Dermato-neuro syndrome in a patient treated with autologous stem cell transplant for scleromyxedema
Samantha R Shams, Daniel A Goldstein, Jonathan L Kaufman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 22, 2017
Cost-Effectiveness of Immune Checkpoint Inhibition in BRAF Wild-Type Advanced Melanoma
Christine G Kohn, Simon B Zeichner, Qiushi Chen, et al.
Leukemia & Lymphoma
|
April 23, 2016
Validation of cutaneous lymphoma international prognostic index (CLIPI) for mycosis fungoides and Sézary syndrome
Hasan H Danish, Shuling Liu, Jaymin Jhaveri, et al.
Medical Care
|
July 30, 2003
Comparing the cost-effectiveness of the triple test score to traditional methods for evaluating palpable breast masses
Arden M Morris, Christopher R Flowers, Katherine T Morris, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
April 29, 2019
Racial and Socioeconomic Disparities in Mantle Cell Lymphoma
Nikesh N Shah, Yizhao Xi, Yuan Liu, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
July 24, 2014
Evaluating cell-of-origin subtype methods for predicting diffuse large B-cell lymphoma survival: a meta-analysis of gene expression profiling and immunohistochemistry algorithms
Jay A Read, Jean L Koff, Loretta J Nastoupil, et al.
Medical Oncology (Northwood, London, England)
|
April 13, 2016
Cost description of chemotherapy regimens for the treatment of metastatic pancreas cancer
Daniel A Goldstein, Kavya Krishna, Christopher R Flowers, et al.
Leukemia & Lymphoma
|
September 29, 2015
Population-specific prognostic models are needed to stratify outcomes for African-Americans with diffuse large B-cell lymphoma
Qiushi Chen, Turgay Ayer, Loretta J Nastoupil, et al.
Frontiers in Immunology
|
February 20, 2025
Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE
Mi-Ae Lyu, Ximing Tang, Maria Gabriela Raso, et al.
The Oncologist
|
August 12, 2017
The Search for Surrogate Endpoints in Trials in Diffuse Large B-Cell Lymphoma: The Surrogate Endpoints for Aggressive Lymphoma Project
Daniel J Sargent, Qian Shi, Christopher R Flowers, et al.
Page
of 43
Search research articles
Search
Showing results (141-150 of 430) with videos related to
Sort By:
Page
of 43
Clinical Lymphoma, Myeloma & Leukemia
|
July 29, 2014
Dermato-neuro syndrome in a patient treated with autologous stem cell transplant for scleromyxedema
Samantha R Shams, Daniel A Goldstein, Jonathan L Kaufman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 22, 2017
Cost-Effectiveness of Immune Checkpoint Inhibition in BRAF Wild-Type Advanced Melanoma
Christine G Kohn, Simon B Zeichner, Qiushi Chen, et al.
Leukemia & Lymphoma
|
April 23, 2016
Validation of cutaneous lymphoma international prognostic index (CLIPI) for mycosis fungoides and Sézary syndrome
Hasan H Danish, Shuling Liu, Jaymin Jhaveri, et al.
Medical Care
|
July 30, 2003
Comparing the cost-effectiveness of the triple test score to traditional methods for evaluating palpable breast masses
Arden M Morris, Christopher R Flowers, Katherine T Morris, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
April 29, 2019
Racial and Socioeconomic Disparities in Mantle Cell Lymphoma
Nikesh N Shah, Yizhao Xi, Yuan Liu, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
July 24, 2014
Evaluating cell-of-origin subtype methods for predicting diffuse large B-cell lymphoma survival: a meta-analysis of gene expression profiling and immunohistochemistry algorithms
Jay A Read, Jean L Koff, Loretta J Nastoupil, et al.
Medical Oncology (Northwood, London, England)
|
April 13, 2016
Cost description of chemotherapy regimens for the treatment of metastatic pancreas cancer
Daniel A Goldstein, Kavya Krishna, Christopher R Flowers, et al.
Leukemia & Lymphoma
|
September 29, 2015
Population-specific prognostic models are needed to stratify outcomes for African-Americans with diffuse large B-cell lymphoma
Qiushi Chen, Turgay Ayer, Loretta J Nastoupil, et al.
Frontiers in Immunology
|
February 20, 2025
Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE
Mi-Ae Lyu, Ximing Tang, Maria Gabriela Raso, et al.
The Oncologist
|
August 12, 2017
The Search for Surrogate Endpoints in Trials in Diffuse Large B-Cell Lymphoma: The Surrogate Endpoints for Aggressive Lymphoma Project
Daniel J Sargent, Qian Shi, Christopher R Flowers, et al.
Page
of 43